Rockville company leads vaccine project

Published



A Rockville-based biotech company at the forefront of the malaria vaccine effort will benefit from a $29 million grant from the Bill and Melinda Gates Foundation.

The PATH Malaria Vaccine Initiative will channel most of the Gates grant to Sanaria Inc., which has spent $14 million developing a viable malaria vaccine.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.